Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1957 1
1960 3
1961 2
1962 2
1963 1
1964 3
1965 4
1966 2
1967 2
1968 7
1969 4
1970 5
1971 5
1972 8
1973 8
1974 21
1975 9
1976 9
1977 5
1978 10
1979 15
1980 13
1981 15
1982 25
1983 15
1984 16
1985 11
1986 12
1987 14
1988 16
1989 10
1990 12
1991 13
1992 8
1993 14
1994 19
1995 17
1996 15
1997 20
1998 15
1999 10
2000 15
2001 15
2002 9
2003 17
2004 10
2005 18
2006 12
2007 15
2008 14
2009 9
2010 19
2011 18
2012 10
2013 14
2014 16
2015 18
2016 14
2017 14
2018 9
2019 11
2020 16
2021 19
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

698 results
Results by year
Filters applied: . Clear all
Page 1
Organoid Modeling of the Tumor Immune Microenvironment.
Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR, Deutsch BC, Liao L, Zemek AJ, Zhao F, Karlsson K, Schultz LM, Metzner TJ, Nadauld LD, Tseng YY, Alkhairy S, Oh C, Keskula P, Mendoza-Villanueva D, De La Vega FM, Kunz PL, Liao JC, Leppert JT, Sunwoo JB, Sabatti C, Boehm JS, Hahn WC, Zheng GXY, Davis MM, Kuo CJ. Neal JT, et al. Among authors: karlsson k. Cell. 2018 Dec 13;175(7):1972-1988.e16. doi: 10.1016/j.cell.2018.11.021. Cell. 2018. PMID: 30550791 Free PMC article.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW, Kamdar M, Munir T, Walewska R, Corbett G, Fogliatto LM, Herishanu Y, Banerji V, Coutre S, Follows G, Walker P, Karlsson K, Ghia P, Janssens A, Cymbalista F, Woyach JA, Salles G, Wierda WG, Izumi R, Munugalavadla V, Patel P, Wang MH, Wong S, Byrd JC. Sharman JP, et al. Among authors: karlsson k. Lancet. 2020 Apr 18;395(10232):1278-1291. doi: 10.1016/S0140-6736(20)30262-2. Lancet. 2020. PMID: 32305093 Free PMC article. Clinical Trial.
A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation.
Lo YH, Kolahi KS, Du Y, Chang CY, Krokhotin A, Nair A, Sobba WD, Karlsson K, Jones SJ, Longacre TA, Mah AT, Tercan B, Sockell A, Xu H, Seoane JA, Chen J, Shmulevich I, Weissman JS, Curtis C, Califano A, Fu H, Crabtree GR, Kuo CJ. Lo YH, et al. Among authors: karlsson k. Cancer Discov. 2021 Jun;11(6):1562-1581. doi: 10.1158/2159-8290.CD-20-1109. Epub 2021 Jan 15. Cancer Discov. 2021. PMID: 33451982 Free PMC article.
Weighting power by preference eliminates gender differences.
Sikström S, Stoinski LM, Karlsson K, Stille L, Willander J. Sikström S, et al. Among authors: karlsson k. PLoS One. 2020 Nov 5;15(11):e0234961. doi: 10.1371/journal.pone.0234961. eCollection 2020. PLoS One. 2020. PMID: 33151957 Free PMC article.
698 results